報價延遲最少15分鐘:2024/06/21 01:28 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.15 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.18/-1.42
|
|
企業價值
758.15M
|
| 資產負債 |
|
每股賬面淨值
2.03
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/06/21 01:28 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |